Literature DB >> 17855835

Antioxidant treatment prevented late memory impairment in an animal model of sepsis.

Tatiana Barichello1, Roberta Albino Machado, Larissa Constantino, Samira S Valvassori, Gislaine Z Réus, Marcio Rodrigo Martins, Fabricia Petronilho, Cristiane Ritter, João Quevedo, Felipe Dal-Pizzol.   

Abstract

OBJECTIVE: Assess the effect of antioxidant treatment on late memory impairment and early hippocampus oxidative stress after cecal ligation and perforation.
SUBJECTS: Male Wistar rats.
INTERVENTIONS: Rats underwent sham operation or cecal ligation and perforation. Animals that underwent cecal ligation and perforation were divided into groups: 1) treated with basic support (50 mL/kg saline, 30 mg/kg ceftriaxone, and 25 mg/kg clindamycin every 6 hrs), 2) treated with basic support plus N-acetylcysteine (20 mg/kg N-acetylcysteine at 3, 6, 12, 18, and 24 hrs after cecal ligation and perforation), 3) treated with basic support plus deferoxamine (20 mg/kg deferoxamine at 3 and 24 hrs after cecal ligation and perforation), 4) treated with basic support plus N-acetylcysteine and deferoxamine, or 5) treated with N-acetylcysteine plus deferoxamine.
MEASUREMENTS AND MAIN RESULTS: On days 10 and 30 after surgery, the animals underwent behavioral tasks: inhibitory avoidance task, habituation to an open field, and continuous multiple-trials step-down inhibitory avoidance task. The sepsis group showed significantly decreased performance in latency retention compared with the sham group in the inhibitory avoidance task. In the open-field task, the sepsis group presented memory impairment after sepsis. In the continuous multiple-trials step-down inhibitory avoidance task, the sepsis group showed a significant increase in the number of training trials required to reach the acquisition criterion. All these memory impairments were prevented by N-acetylcysteine plus deferoxamine treatment, but not its isolate use. In addition, the combined use of antioxidants attenuated oxidative damage in hippocampus 6 hrs after sepsis induction.
CONCLUSIONS: Antioxidant treatment prevented the development of late cognitive deficits in an animal model of sepsis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855835     DOI: 10.1097/01.ccm.0000281452.60683.96

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  30 in total

1.  Acute brain inflammation and oxidative damage are related to long-term cognitive deficits and markers of neurodegeneration in sepsis-survivor rats.

Authors:  Mágada T Schwalm; Matheus Pasquali; Samantha P Miguel; João Paulo A Dos Santos; Francieli Vuolo; Clarissa M Comim; Fabrícia Petronilho; João Quevedo; Daniel P Gelain; José Cláudio F Moreira; Cristiane Ritter; Felipe Dal-Pizzol
Journal:  Mol Neurobiol       Date:  2013-08-30       Impact factor: 5.590

2.  Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats.

Authors:  Tatiana Barichello; Ana Lucia B Santos; Geovana D Savi; Jaqueline S Generoso; Paola Otaran; Cleonice M Michelon; Amanda V Steckert; Francielle Mina; Clarissa M Comim; Felipe Dal-Pizzol; João Quevedo
Journal:  Metab Brain Dis       Date:  2012-05-17       Impact factor: 3.584

3.  Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.

Authors:  Michelle A Erickson; Kim Hansen; William A Banks
Journal:  Brain Behav Immun       Date:  2012-07-15       Impact factor: 7.217

Review 4.  Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.

Authors:  Robert A Floyd; Hugo C Castro Faria Neto; Guy A Zimmerman; Kenneth Hensley; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2013-02-16       Impact factor: 7.376

5.  The decrease on Na(+), K(+)-ATPase activity in the cortex, but not in hippocampus, is reverted by antioxidants in an animal model of sepsis.

Authors:  Isabela Casagrande Jeremias; Giselli Scaini; Larissa Constantino; Francieli Vuolo; Andreia Kurek Ferreira; Emilene Barros Silva Scherer; Janaina Kolling; Arethuza da Silva Dornelles; Angela Terezinha de Souza Wyse; Maurício Reis Bogo; Felipe Dal-Pizzol; Emilio Luiz Streck
Journal:  Mol Neurobiol       Date:  2012-07-04       Impact factor: 5.590

6.  CD40-CD40 Ligand Pathway is a Major Component of Acute Neuroinflammation and Contributes to Long-term Cognitive Dysfunction after Sepsis.

Authors:  Monique Michels; Lucinéia Gainski Danieslki; Andriele Vieira; Drielly Florentino; Dhébora Dall'Igna; Letícia Galant; Beatriz Sonai; Francieli Vuolo; Franciele Mina; Bruna Pescador; Diogo Dominguini; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Fabrícia Petronilho
Journal:  Mol Med       Date:  2015-03-26       Impact factor: 6.354

Review 7.  Neuro-oxidative-nitrosative stress in sepsis.

Authors:  Ronan M G Berg; Kirsten Møller; Damian M Bailey
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-13       Impact factor: 6.200

8.  Dimethyl Fumarate Modulates Oxidative Stress and Inflammation in Organs After Sepsis in Rats.

Authors:  Amanda Della Giustina; Sandra Bonfante; Graciela Freitas Zarbato; Lucinéia Gainski Danielski; Khiany Mathias; Aloir Neri de Oliveira; Leandro Garbossa; Taise Cardoso; Maria Eduarda Fileti; Raquel Jaconi De Carli; Mariana Pereira Goldim; Tatiana Barichello; Fabricia Petronilho
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

9.  Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.

Authors:  Juciano Gasparotto; Carolina S Girardi; Nauana Somensi; Camila T Ribeiro; José C F Moreira; Monique Michels; Beatriz Sonai; Mariane Rocha; Amanda V Steckert; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Daniel P Gelain
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

10.  Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.

Authors:  Patricia A Reis; Clarissa M Comim; Fernanda Hermani; Bruno Silva; Tatiana Barichello; Aline C Portella; Flavia C A Gomes; Ive M Sab; Valber S Frutuoso; Marcus F Oliveira; Patricia T Bozza; Fernando A Bozza; Felipe Dal-Pizzol; Guy A Zimmerman; João Quevedo; Hugo C Castro-Faria-Neto
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.